Skip to main content
Quest Diagnostics

Proteomic Determinants of Variation in Cholesterol Efflux: Observations From the Dallas Heart Study

Proteomic Determinants of Variation in Cholesterol Efflux: Observations From the Dallas Heart Study

Authors: Pearce RW, Collier TS, McPhaul MJ

Citation: Int J Mol Sci. 2023 Oct 24;24(21):15526. doi: 10.3390/ijms242115526

Specialties: Cardiology, Endocrinology

Related content

Conference Presentation
HDL Containing Specific Proteins Blunts the Association with Cholesterol Efflux Capacity: Observations from the Dallas Heart Study
On-Demand Webinar
Cardiovascular Clinical Conversations: Understanding the Function of HDL—Beyond Its Levels
Conference Presentation
Presence of Type 2 Diabetes (T2D) Affects HDL Particle Proteomic Composition Independently of Obesity or Fatty Liver
On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.